Ha, I just checked and as of today I've been in this stonk exactly for one year ( at a cost basis of $.30), which means LTCG when I decide to sell. The general logic in r/pennystocks is usually highly regarded, so I wouldnt use that as justification for buying, but I will add the CEO has made it very clear his goal is to sell the company by the end of the year or uplist to the nasdaq. They just completed a new US manufacturing facility that dramatically increases their production capacity, so they may have some value for pharma's looking to onshore production with Trumps tariff BS. They make generic drugs, so its not sexy high margin GLP-1 shit. But you cant argue that the CEO's plan to goose revenues through the release of a bunch of new products hasn't been successful:
I'm holding through the end of the year regardless as an acquisition would be my desired exit, but the business is also trending in the right direction.